Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-07

FDA Approved: ALMOTRIPTAN — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ALMOTRIPTAN (almotriptan) from Ajanta Pharma USA Inc., signaling an update to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALMOTRIPTAN (almotriptan)

Snippet

SUPPL AP for ALMOTRIPTAN (ALMOTRIPTAN)